| CCB Deadline Alert: Levi & Korsinsky Reminds Coastal Financial Corporation (CCB) Investors of Securities Class Action Deadline on December 1, 2026 |
Globe Newswire |
11/09 |
10:11 |
| HONA Shareholder Alert: Honeywell Aerospace Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky |
Globe Newswire |
11/09 |
10:10 |
| BETR Shareholder Alert: Better Home & Finance Holding Company Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky |
Globe Newswire |
11/09 |
10:10 |
| Levi & Korsinsky Reminds Qfin Holdings, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 27, 2026 - QFIN |
Globe Newswire |
11/09 |
10:10 |
| ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact Levi & Korsinsky |
Globe Newswire |
11/09 |
10:09 |
| Ionis Pharmaceuticals (IONS) Shares Drop Following Sharp Reduction in TRYNGOLZA Sales Forecast – Kehoe Law Firm, P.C. Investigating |
Globe Newswire |
11/09 |
10:08 |
| DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class Action - Contact Levi & Korsinsky |
Globe Newswire |
11/09 |
10:08 |
| Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2026 in Lincoln Educational Services Corporation Lawsuit - LINC |
Globe Newswire |
11/09 |
10:05 |
| Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2026 in FuelCell Energy, Inc. Lawsuit - FCEL |
Globe Newswire |
11/09 |
10:04 |
| OI Shareholder Alert: O-I Glass, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky |
Globe Newswire |
11/09 |
10:03 |
| Levi & Korsinsky Reminds Baidu, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 13, 2026 - BIDU |
Globe Newswire |
11/09 |
10:03 |
| Veloce Brand, Agency, Esports Partnerships and Quadrant Drive SEGG Media Q2 1,584% Revenue Increase |
Globe Newswire |
11/09 |
10:00 |
| Reach Security Recognized as a CRN® 2026 Stellar Startup |
Globe Newswire |
11/09 |
10:00 |
| DTN Announces Three Key Executive Appointments To Drive Innovation and Growth |
Globe Newswire |
11/09 |
10:00 |
| Freight Club Leadership Joins Freight Right to Build Out Direct-to-Consumer Ecommerce and Dropshipping for Large Goods |
Globe Newswire |
11/09 |
10:00 |
| Bronstein, Gewirtz & Grossman LLC Urges The Ensign Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
11/09 |
10:00 |
| National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported |
Globe Newswire |
11/09 |
10:00 |
| The Goddard School Opens 700th School, Marking Major Growth Milestone |
Globe Newswire |
11/09 |
10:00 |
| Silvercrest Asset Management Group Ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings Among Consultants and Asset Owners in the Mid-Sized Firm Peer Universe |
Globe Newswire |
11/09 |
10:00 |
| Kraig Labs Ships Spider Silk to Developers Across Global Industries |
Globe Newswire |
11/09 |
09:55 |
| From Artemis to Supersonic Flight, the President Takes the Aerospace Agenda to the Space Coast |
Globe Newswire |
11/09 |
09:52 |
| CloudTalk launches a new AI Sales Dialer for even more live conversations: Customers report going from 15 to 100+ calls per agent per day |
Globe Newswire |
11/09 |
09:52 |
| Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits |
Globe Newswire |
11/09 |
09:45 |
| Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits |
Globe Newswire |
11/09 |
09:45 |
| Texas Capital Bancshares, Inc. Begins Trading on TXSE Under New TXCP Ticker |
Globe Newswire |
11/09 |
09:45 |
